Ottavio V. Vitolo
Keine laufenden Positionen mehr
Profil
Ottavio V.
Vitolo worked as a Senior Medical Director at Pfizer Inc. from 2013 to 2017, an Associate Medical Director at Shire Human Genetic Therapies, Inc. from 2012 to 2013, Vice President of Clinical Development at Homology Medicines, Inc. from 2017 to 2018, and Chief Medical Officer & Senior Vice President at Relmada Therapeutics, Inc. from 2018 to 2020.
Vitolo holds a doctorate from Sapienza University of Rome and a graduate degree from Harvard Medical School.
Ehemalige bekannte Positionen von Ottavio V. Vitolo
| Unternehmen | Position | Ende |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.03.2020 |
| Q32 BIO INC. | Corporate Officer/Principal | 01.03.2018 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2017 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01.04.2013 |
Ausbildung von Ottavio V. Vitolo
| Harvard Medical School | Graduate Degree |
| Sapienza University of Rome | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
